CRISPR/Cas9 bioluminescence-based assay for monitoring CFTR trafficking to the plasma membrane
Life Science Alliance · 2024
DOI: 10.26508/lsa.202302045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, 2024. Verfasst von Martin Ondra und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic. Hauptthemen laut MEDLINE: Cystic Fibrosis Transmembrane Conductance Regulator, Cystic Fibrosis. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Quebec Ministry of Economy and Innovation, Ministry of School and Education of the Czech Republic, CIHR.
Abstract (Originalsprache)
CFTR is a membrane protein that functions as an ion channel. Mutations that disrupt its biosynthesis, trafficking or function cause cystic fibrosis (CF). Here, we present a novel in vitro model system prepared using CRISPR/Cas9 genome editing with endogenously expressed WT-CFTR tagged with a HiBiT peptide. To enable the detection of CFTR in the plasma membrane of live cells, we inserted the HiBiT tag in the fourth extracellular loop of WT-CFTR. The 11-amino acid HiBiT tag binds with high affinity to a large inactive subunit (LgBiT), generating a reporter luciferase with bright luminescence. Nine homozygous clones with the HiBiT knock-in were identified from the 182 screened clones; two were genetically and functionally validated. In summary, this work describes the preparation and validation of a novel reporter cell line with the potential to be used as an ultimate building block for developing unique cellular CF models by CRISPR-mediated insertion of CF-causing mutations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
- Czech Advanced Technology and Research Institute, Palacky University, Olomouc, Czech Republic.
- Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada.
- RI-MUHC, Montreal, Canada.
- Physiology, McGill University, Montreal, Canada.
- Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic danuta.radzioch@mcgill.ca.
ORCID-Profile: Martin Ondra, John W Hanrahan, Juan Bautista De Sanctis, Danuta Radzioch, Marian Hajduch
Förderung
- The Quebec Ministry of Economy and Innovation
- Ministry of School and Education of the Czech Republic
- CIHR
- RI-MUHC
Zitieren
APA
Ondra, M., Lenart, L., Centorame, A., Dumut, D. C., He, A., Zaidi, S. S. Z., Hanrahan, J. W., De Sanctis, J. B., Radzioch, D., & Hajduch, M. (2024). CRISPR/Cas9 bioluminescence-based assay for monitoring CFTR trafficking to the plasma membrane. Life Science Alliance. https://doi.org/10.26508/lsa.202302045
Vancouver
Ondra M, Lenart L, Centorame A, Dumut DC, He A, Zaidi SSZ, et al. CRISPR/Cas9 bioluminescence-based assay for monitoring CFTR trafficking to the plasma membrane. Life Science Alliance. 2024. doi:10.26508/lsa.202302045
BibTeX
@article{Ondra2024,
author = {Ondra, Martin and Lenart, Lukas and Centorame, Amanda and Dumut, Daciana C and He, Alexander and Zaidi, Syeda Sadaf Zehra and Hanrahan, John W and De Sanctis, Juan Bautista and Radzioch, Danuta and Hajduch, Marian},
title = {CRISPR/Cas9 bioluminescence-based assay for monitoring CFTR trafficking to the plasma membrane},
journal = {Life Science Alliance},
year = {2024},
doi = {10.26508/lsa.202302045}
}
EUVIMED